絞り込み

16641

広告

Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE mice.

著者 Zhang L , Li P , Tang Z , Dou Q , Feng B
Ann Transl Med.2019 Aug ; 7(16):369.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (25view , 0users)

Full Text Sources

Miscellaneous

It has been reported that glucagon-like peptide-1 (GLP-1) can alleviate diabetic osteoporosis (DOP). This study was to investigate the effects of GLP-1RA liraglutide and dipeptidyl peptdase-4 (DPP-4) inhibitor vildagliptin on the advanced glycation end products (AGEs)-induced bone injury in ApoE mice with euglycemia.
PMID: 31555683 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード